In a GWAS with 561 Icelandic individuals with thyroid cancer cases and 40,013 controls, DIRC3 variants were associated both with thyroid cancer risk and thyroid stimulating hormone levels. This evidence concerns the gene DIRC3 and thyroid cancer.